BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30156549)

  • 1. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
    Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
    Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
    Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
    De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
    Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
    Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
    Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjögren's syndrome.
    Notarstefano C; Croia C; Pontarini E; Lucchesi D; Sutcliffe N; Tappuni A; Donati V; Pitzalis C; Baldini C; Bombardieri M
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):145-149. PubMed ID: 30156540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario?
    Bartoloni E; Baldini C; Ferro F; Alunno A; Carubbi F; Cafaro G; Bombardieri S; Gerli R; Grossi E
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):133-139. PubMed ID: 31464678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
    Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
    Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome.
    Luo J; Xu S; Lv Y; Huang X; Zhang H; Zhu X; Wang X
    Int J Rheum Dis; 2019 Feb; 22(2):182-190. PubMed ID: 30411528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
    Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes?
    Baldini C; Delle Sedie A; Luciano N; Pepe P; Ferro F; Talarico R; Tani C; Mosca M
    Rheumatol Int; 2014 Aug; 34(8):1159-64. PubMed ID: 24097207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
    Risselada AP; Kruize AA; Bijlsma JW
    Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of major salivary gland ultrasonography in primary Sjögren's syndrome.
    Hammenfors DS; Brun JG; Jonsson R; Jonsson MV
    Clin Exp Rheumatol; 2015; 33(1):56-62. PubMed ID: 25535773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
    Ter Borg EJ; Kelder JC
    Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical picture, outcome and predictive factors of lymphoma in Sjӧgren syndrome.
    Papageorgiou A; Voulgarelis M; Tzioufas AG
    Autoimmun Rev; 2015 Jul; 14(7):641-9. PubMed ID: 25808075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary Sjogren's syndrome: clinical and serological feature of a single centre].
    Baldini C; Tavoni A; Merlini G; Sebastiani M; Bombardieri S
    Reumatismo; 2005 Dec; 57(4):256-61. PubMed ID: 16380752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
    Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of diagnosis and disease course in primary Sjögren's syndrome: Results from datamining of electronic health records.
    Sandhya P; Janardana R; Sudarsanam T; Mahasampath G; Prakash JAJ; Danda D
    Int J Rheum Dis; 2019 Sep; 22(9):1768-1774. PubMed ID: 31328441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.